Entrada Therapeutics Inc (TRDA)
12.24
+0.39
(+3.29%)
USD |
NASDAQ |
May 01, 12:12
Entrada Therapeutics Price: 12.24 for May 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 30, 2024 | 12.29 | 12.39 | 11.82 | 11.85 | 66257.00 |
Apr 29, 2024 | 12.33 | 12.55 | 12.06 | 12.34 | 52697.00 |
Apr 26, 2024 | 12.10 | 12.73 | 12.10 | 12.45 | 25818.00 |
Apr 25, 2024 | 12.23 | 12.58 | 11.91 | 12.36 | 84124.00 |
Apr 24, 2024 | 12.79 | 12.79 | 12.31 | 12.43 | 38559.00 |
Apr 23, 2024 | 13.08 | 14.03 | 12.78 | 12.89 | 43975.00 |
Apr 22, 2024 | 12.24 | 13.13 | 12.20 | 13.10 | 119085.0 |
Apr 19, 2024 | 11.83 | 12.19 | 11.81 | 12.15 | 87455.00 |
Apr 18, 2024 | 12.12 | 12.40 | 11.82 | 11.91 | 130286.0 |
Apr 17, 2024 | 12.71 | 12.89 | 12.16 | 12.22 | 56429.00 |
Apr 16, 2024 | 12.87 | 13.00 | 12.52 | 12.72 | 49596.00 |
Apr 15, 2024 | 13.03 | 13.54 | 12.69 | 12.89 | 108935.0 |
Apr 12, 2024 | 13.18 | 13.51 | 12.76 | 12.95 | 55707.00 |
Apr 11, 2024 | 12.75 | 13.29 | 12.18 | 13.26 | 92942.00 |
Apr 10, 2024 | 12.92 | 13.32 | 12.23 | 12.52 | 181822.0 |
Apr 09, 2024 | 13.58 | 13.66 | 13.00 | 13.28 | 69240.00 |
Apr 08, 2024 | 13.89 | 14.13 | 13.39 | 13.45 | 56882.00 |
Apr 05, 2024 | 13.83 | 14.06 | 13.52 | 13.81 | 104020.0 |
Apr 04, 2024 | 14.08 | 14.34 | 13.68 | 13.83 | 52003.00 |
Apr 03, 2024 | 13.62 | 14.22 | 13.62 | 13.81 | 55651.00 |
Apr 02, 2024 | 13.60 | 13.96 | 13.17 | 13.88 | 64911.00 |
Apr 01, 2024 | 14.38 | 14.38 | 13.41 | 13.76 | 70850.00 |
Mar 28, 2024 | 14.51 | 14.51 | 13.67 | 14.17 | 105311.0 |
Mar 27, 2024 | 13.99 | 14.50 | 13.66 | 14.35 | 46092.00 |
Mar 26, 2024 | 13.46 | 14.00 | 13.26 | 13.76 | 68029.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.49
Minimum
May 09 2022
35.00
Maximum
Nov 17 2021
14.13
Average
13.99
Median
Sep 21 2022
Price Benchmarks
GlycoMimetics Inc | 1.75 |
Lyell Immunopharma Inc | 2.265 |
Candel Therapeutics Inc | 7.26 |
Eliem Therapeutics Inc | 6.88 |
NovaBay Pharmaceuticals Inc | 0.0834 |
Price Related Metrics
PS Ratio | 3.171 |
Price to Book Value | 1.697 |
Price to Free Cash Flow | 3.049 |
Earnings Yield | -2.12% |
Market Cap | 411.28M |